In our study, the results showed that Rh4 could target SIX1 to inhibit the TGF-β/Smad2/3 signaling pathway and effectively suppressed EMT metastasis in GC cells according to the wound healing assay, transwell assay, proteome sequencing, and Western blot. The gene discussed is SMAD2; the disease is gastric cancer.